| Closed |
SWOG-8741 |
A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Refractory Carcinoma of the Breast |
9/15/1988 |
11/15/1990 |
63% |
|
Published
|
| Closed |
SWOG-8744 |
A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Refractory Multiple Myeloma |
8/1/1988 |
11/15/1990 |
27% |
|
|
| Closed |
SWOG-9511 |
A Phase II Study of Trimetrexate, 5-FU and Leucovorin in Unresectable or Metastatic Adenocarcinoma of the Stomach |
1/15/1997 |
11/15/1998 |
100% |
|
Published
|
| Closed |
S9629 |
A Phase II Trial of 5-Fluorouracil Plus 776C85 in Patients with Advanced Pancreas Cancer |
5/15/1997 |
3/15/1999 |
100% |
|
Published
|
| Closed |
SWOG-8828 |
A Phase II Trial of Carboplatin (CBDCA) in Relapsed or Refractory Acute Myeloid Leukemia |
11/15/1989 |
10/15/1992 |
82% |
|
Published
|
| Closed |
SWOG-9504 |
A Phase II Trial of Concurrent Cisplatin/VP-16 and Radiotherapy Followed by Consolidation Docetaxel (Taxotere®) in Stage III-B Non-Small Cell Lung Cancer |
10/15/1996 |
12/1/1998 |
100% |
|
Published
|
| Closed |
SWOG-9240 |
A Phase II Trial of CVAD for Treatment of Non-Hodgkin's Lymphoma |
1/15/1993 |
2/1/1994 |
100% |
|
Published
|
| Closed |
SWOG-9125 |
A Phase II Trial of CVAD/Verapamil/Quinine for Treatment of Non-Hodgkin's Lymphoma |
6/1/1991 |
2/15/1993 |
100% |
|
Published
|
| Closed |
SWOG-9501 |
A Phase II Trial of Fludarabine and Mitoxantrone (FN) for Treatment of Non-Hodgkin's Lymphoma |
4/1/1995 |
2/15/1996 |
100% |
|
Published
|
| Closed |
SWOG-9058 |
A Phase II Trial of Intravenous Vinorelbine (Navelbine®) in Previously Untreated Extensive Small Cell Lung Carcinoma |
5/15/1992 |
6/1/1995 |
46% |
|
Published
|
| Closed |
SWOG-9248 |
A Phase II Trial of Paclitaxel (Taxol ®) in Patients with Metastatic Refractory Carcinoma of the Breast |
6/1/1993 |
2/1/1994 |
100% |
|
Published
|
| Closed |
SWOG-9443 (NABTC-9402) (NCI T94-0087) |
A Phase II Trial of Phenylacetic Acid for Recurrent Malignant Glioma and Primitive Neuroectodermal Tumors: A Clinical and Pharmacokinetics Study of the North American Brain Tumor Consortium |
12/27/1994 |
12/15/1997 |
100% |
|
|
| Closed |
SWOG-9134 |
A Phase II Trial of Taxol and Granulocyte-Colony Stimulating Factor (G-CSF) in Patients with Advanced Soft-Tissue Sarcoma |
6/1/1992 |
6/15/1993 |
100% |
|
Published
|
| Closed |
SWOG-9135 |
A Phase II Trial of Taxol and Granulocyte-Colony Stimulating Factor (G-CSF) in Patients with Pancreatic Adenocarcinoma |
6/1/1992 |
1/15/1993 |
|
|
Published
|
| Closed |
SWOG-8721 |
A Phase II Trial of Trimetrexate in the Treatment of Esophageal Cancer |
9/1/1987 |
9/1/1991 |
69% |
|
Published
|
| Closed |
SWOG-8623 |
A Phase II Trial of Trimetrexate in Untreated Advanced Gastric Carcinoma |
8/15/1987 |
1/1/1989 |
|
|
Published
|
| Closed |
SWOG-8516 (INT-0067) |
A Phase III Comparison of CHOP Versus m-BACOD Versus ProMACE-CytaBOM Versus MACOP-B in Patients with Intermediate or High-Grade Non-Hodgkin's Lymphoma |
4/4/1986 |
6/15/1991 |
100% |
|
Published
|
| Closed |
SWOG-9028 |
A Phase III Randomized Trial of Combination Therapy for Multiple Myeloma Comparison of (1) VAD to VAD/ Quinine for Induction with Crossover to VAD/ Quinine for VAD Induction Failures; (2) Alpha-2b… |
10/1/1990 |
5/15/1994 |
39% |
|
Published
|
| Closed |
SWOG-9210 |
A Phase III Randomized Trial of Combination Therapy for Multiple Myeloma Comparison of (1) VAD-P to VAD-P/Quinine for Induction; (2) Randomization of Prednisone Dose Intensity For Remission… |
3/15/1993 |
9/1/1998 |
60% |
|
Published
|
| Closed |
SWOG-8624 |
A Phase III Randomized Trial of Combination Therapy for Multiple Myeloma; Comparison of (1) VMCP/VBAP to VAD or VMCPP/VBAPP for Induction; (2) Alpha-2b Interferon or No Therapy for Maintenance; and 3… |
2/1/1987 |
10/1/1990 |
100% |
|
Published
|
